Skip to main content
    A

    Atrium Therapeutics, Inc. Common Stock (RNA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.48
    +0.05 (+0.78%)

    Market Cap: $162.00M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Atrium Therapeutics, Inc. Common Stock (RNA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Atrium Therapeutics, Inc. Common Stock (RNA) has a latest price of $6.48 on Nov 17, 2026, 61.4% below its 52-week high of $16.77. Its price fell 90.8% over the past 12 months. The month-end price fell 63.2% over the 5 years through Oct 2026, a compound annual decline of 18.1%.

    Price Chart

    From Jun 2020 to Oct 2026, its highest month-end close was $72.57 in Jan 2026 and its lowest $5.15 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart RNA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RNA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 52.7%, and over 6 months it fell 50.0%. The month-end price rose 60.6% over the 3 years through Oct 2026, a compound annual rate of 17.1%.

    PeriodChange
    1 month-14.8%
    3 months-52.7%
    6 months-50.0%
    12 months-90.8%
    12 months, with dividends-90.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+60.6%+17.1%
    5 years-63.2%-18.1%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 221.3%, and its weakest was 2023, when it fell 59.2%.

    YearCloseChange
    2026 through Oct 2026$8.27-88.5%
    2025$72.13+148.0%
    2024$29.08+221.3%
    2023$9.05-59.2%
    2022$22.19-6.6%
    2021$23.77-6.9%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 22.8% below its 50-day average of $8.40 and 61.9% below its 200-day average of $16.99.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$6.48
    52-week high$16.77-61.4%
    52-week low$6.36+1.9%
    50-day average$8.40-22.8%
    200-day average$16.99-61.9%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 91.2%.

    MeasureValue
    1-year beta1.38
    Largest fall, 1 year-91.2%
    Largest fall, 3 years-91.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About RNA

    What is RNA's 1-year price change?

    Atrium Therapeutics, Inc. Common Stock's price fell 90.8% over the past 12 months. With dividends included, the 12-month total return was -90.8%.

    What is RNA's 5-year price change?

    Atrium Therapeutics, Inc. Common Stock's month-end price fell 63.2% over the 5 years through Oct 2026, a compound annual decline of 18.1%. These figures leave out dividends.

    What is RNA's 52-week high and low?

    Atrium Therapeutics, Inc. Common Stock's 52-week high is $16.77 and its 52-week low is $6.36. Its latest price of $6.48 on Nov 17, 2026 is 61.4% below the high.

    What is RNA's beta?

    Atrium Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 1.38, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 91.2%.

    Is the RNA chart free?

    Yes. Advanced Charting for RNA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.